Viewing nowAvatin 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Hwa-il Pharmaceutical Co., Ltd.

MFDS item code 201401233 · Approved 2014.03.18 · Insurance code 684501040
Improvement of hyperlipidemia and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, it lowers the risk of various cardiovascular complications such as myocardial infarction, stroke, congestive heart failure, and angina. In patients with hyperlipidemia, it is used to reduce total cholesterol and LDL cholesterol levels while increasing HDL cholesterol levels to improve the lipid profile. It is particularly effective in treating patients with dyslipidemia who do not respond to dietary changes or those with homozygous familial hypercholesterolemia. Furthermore, it is also utilized in treating hypercholesterolemia in pediatric patients aged 10 to 17 who meet certain conditions. This medication is used to reduce the risk of cardiovascular diseases and improve blood lipid levels.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45% or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks of starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. ○ Elderly patients: Efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Ages 10 ~ 17 years: The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses above 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle problems, and if myalgia or muscle weakness becomes severe, or if creatine kinase (CK) levels rise significantly, use should be stopped immediately. Patients with poor liver function or liver disease should not use this medication and should undergo regular liver function tests. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It is safest not to use in children, especially those under 10 years of age. Caution should be exercised in patients with alcohol dependence or a history of liver disease, renal impairment, and hypothyroidism, and monitoring for muscle-related side effects is necessary. This medication can interact with other drugs; therefore, patients taking certain antibiotics, antifungals, antivirals, immunosuppressants, antihypertensives, or antidiabetic medications should inform their doctor or pharmacist. If symptoms such as myalgia, weakness, or fever occur during treatment, patients should immediately inform healthcare professionals, and blood tests may be necessary to check for muscle damage. This medication may cause liver function abnormalities, skin rashes, allergic reactions, gastrointestinal symptoms, headaches, and dizziness; if symptoms are severe or persistent, patients should consult with healthcare professionals. Elderly patients or those with renal disorders are at higher risk for myopathy and should be monitored closely. There is no specific antidote for overdose, so treatment should be conducted based on symptoms, and liver function and muscle status should be monitored. Keep this medication out of the reach of children and store it in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be kept in a tightly closed container to protect it from air and moisture, at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Hwa-il Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.